CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein
- PMID: 12443671
- DOI: 10.1016/s0264-410x(02)00378-x
CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein
Abstract
Vaccine adjuvants must have the capacity to increase protective immune responses with minimal side effects. Conventional adjuvants not only cause undesirable tissue site reactions, but often induce T-helper type 2 (Th2)-biased responses which may be undesirable in certain disease scenarios. Oligodeoxynucleotides containing unmethylated CpG dinucleotides (CpG ODN) are novel adjuvants known to promote Th1-type immune responses. In this study, we compared various mineral oil, metabolizable oil and non-oil adjuvants alone and in combination with CpG ODN for their ability to augment immune responses to a truncated secreted form of bovine herpesvirus (BHV) glycoprotein D (tgD). All adjuvants tested induced Th2-biased immune responses characterized by a predominance of serum IgG1 as well as interleukin-4 (IL-4) production by in vitro stimulated splenocytes. The inclusion of CpG ODN in these formulations not only increased immune responses, but more importantly enhanced serum IgG2a levels and production of interferon-gamma (IFN-gamma) by splenocytes, indicating a more balanced or Th1-type response. The use of a mineral oil-based adjuvant at reduced doses in combination with CpG ODN attenuated the tissue damage while not compromising the magnitude of the immune response in both mice and sheep. In addition, reduced amounts of mineral oil combined with CpG ODN induced a more balanced Th1/Th2 immune response than the mineral oil used alone. Our results clearly demonstrate that CpG ODN can be used to enhance magnitude and balance of an immune response while reducing the amount of mineral oil and hence undesirable side effects of vaccine adjuvants.
Similar articles
-
Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.J Virol. 2005 Feb;79(4):2024-32. doi: 10.1128/JVI.79.4.2024-2032.2005. J Virol. 2005. PMID: 15681404 Free PMC article.
-
CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D.Vaccine. 2002 Jul 26;20(23-24):3014-22. doi: 10.1016/s0264-410x(02)00216-5. Vaccine. 2002. PMID: 12126915
-
The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides.J Virol. 2002 Sep;76(18):9002-10. doi: 10.1128/jvi.76.18.9002-9010.2002. J Virol. 2002. PMID: 12186884 Free PMC article.
-
CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.Virus Genes. 2005 Mar;30(2):251-66. doi: 10.1007/s11262-004-5632-2. Virus Genes. 2005. PMID: 15744581 Review.
-
CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases.Adv Drug Deliv Rev. 2009 Mar 28;61(3):248-55. doi: 10.1016/j.addr.2008.12.012. Epub 2009 Jan 14. Adv Drug Deliv Rev. 2009. PMID: 19272313 Review.
Cited by
-
Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines.Clin Vaccine Immunol. 2012 Oct;19(10):1633-40. doi: 10.1128/CVI.00235-12. Epub 2012 Aug 15. Clin Vaccine Immunol. 2012. PMID: 22896687 Free PMC article.
-
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.J Virol. 2008 Jan;82(1):115-25. doi: 10.1128/JVI.00927-07. Epub 2007 Oct 17. J Virol. 2008. PMID: 17942537 Free PMC article.
-
Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB/c mice.PLoS Negl Trop Dis. 2017 Dec 18;11(12):e0006123. doi: 10.1371/journal.pntd.0006123. eCollection 2017 Dec. PLoS Negl Trop Dis. 2017. PMID: 29253854 Free PMC article.
-
Therapeutic Chlamydophila abortus and C. pecorum vaccination transiently reduces bovine mastitis associated with Chlamydophila infection.Infect Immun. 2007 Feb;75(2):870-7. doi: 10.1128/IAI.00691-06. Epub 2006 Nov 21. Infect Immun. 2007. PMID: 17118976 Free PMC article.
-
Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines.Vaccine. 2005 Aug 15;23(35):4385-91. doi: 10.1016/j.vaccine.2005.04.011. Vaccine. 2005. PMID: 16005746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources